Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The effects of exposure to solar radiation on human health

Open access
Neale, R. E., Lucas, R. M., Byrne, S. N., Hollestein, L., Rhodes, L. E., Yazar, S., Young, A. R., Berwick, M., Ireland, R. A., Olsen, C. M.·2023·Photochemical & Photobiological Sciences

Abstract

This assessment by the Environmental Effects Assessment Panel (EEAP) of the Montreal Protocol under the United Nations Environment Programme (UNEP) evaluates the effects of ultraviolet (UV) radiation on human health within the context of the Montreal Protocol and its Amendments. We assess work published since our last comprehensive assessment in 2018. Over the last four years gains have been made in knowledge of the links between sun exposure and health outcomes, mechanisms, and estimates of disease burden, including economic impacts. Of particular note, there is new information about the way in which exposure to UV radiation modulates the immune system, causing both harms and benefits for health. The burden of skin cancer remains high, with many lives lost to melanoma and many more people treated for keratinocyte cancer, but it has been estimated that the Montreal Protocol will prevent 11 million cases of melanoma and 432 million cases of keratinocyte cancer that would otherwise have occurred in the United States in people born between 1890 and 2100. While the incidence of skin cancer continues to rise, rates have stabilised in younger populations in some countries. Mortality has also plateaued, partly due to the use of systemic therapies for advanced disease. However, these therapies are very expensive, contributing to the extremely high economic burden of skin cancer, and emphasising the importance and comparative cost-effectiveness of prevention. Photodermatoses, inflammatory skin conditions induced by exposure to UV radiation, can have a marked detrimental impact on the quality of life of sufferers. More information is emerging about their potential link with commonly used drugs, particularly anti-hypertensives. The eyes are also harmed by over-exposure to UV radiation. The incidence of cataract and pterygium is continuing to rise, and there is now evidence of a link between intraocular melanoma and sun exposure. It has been estimated that the Montreal Protocol will prevent 63 million cases of cataract that would otherwise have occurred in the United States in people born between 1890 and 2100. Despite the clearly established harms, exposure to UV radiation also has benefits for human health. While the best recognised benefit is production of vitamin D, beneficial effects mediated by factors other than vitamin D are emerging. For both sun exposure and vitamin D, there is increasingly convincing evidence of a positive role in diseases related to immune function, including both autoimmune diseases and infection. With its influence on the intensity of UV radiation and global warming, the Montreal Protocol has, and will have, both direct and indirect effects on human health, potentially changing the balance of the risks and benefits of spending time outdoors. Graphical abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s43630-023-00375-8

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 273

  1. Andrady, A. L., Heikkila, A. M., Pandey, K. K., Bruckman, L. S., White, C. C., Zhu, M., & Zhu, L. (2023). Effects of UV radiation on natural and synthetic materials. Photochemical & Photobiological Sciences, This issue. https://doi.org/10.1007/s43630-023-00377-6 · DOI · Paper page
  2. Lucas, R. M., Yazar, S., Young, A. R., Norval, M., de Gruijl, F. R., Takizawa, Y., Rhodes, L. E., Sinclair, C. A., & Neale, R. E. (2019). Human health in relation to exposure to solar ultraviolet radiation under changing stratospheric ozone and climate. Photochemical & Photobiological Sciences, 18(3), 641–680. https://doi.org/10.1039/c8pp90060d · DOI · Paper page
  3. Hayward, N. K., Wilmott, J. S., Waddell, N., Johansson, P. A., Field, M. A., Nones, K., Patch, A. M., Kakavand, H., Alexandrov, L. B., Burke, H., Jakrot, V., Kazakoff, S., Holmes, O., Leonard, C., Sabarinathan, R., Mularoni, L., Wood, S., Xu, Q., Waddell, N., Tembe, V., et al. (2017). Whole-genome landscapes of major melanoma subtypes. Nature, 545(7653), 175–180. https://doi.org/10.1038/nature22071 · DOI · Paper page
  4. Lawrence, K. P., Delinasios, G. J., Premi, S., Young, A. R., & Cooke, M. S. (2022). Perspectives on cyclobutane pyrimidine dimers—rise of the dark dimers. Photochemistry and Photobiology, 98(3), 609–616. https://doi.org/10.1111/php.13551 · DOI
  5. Liyanage, U. E., MacGregor, S., Bishop, D. T., Shi, J., An, J., Ong, J. S., Han, X., Scolyer, R. A., Martin, N. G., Medland, S. E., Byrne, E. M., Green, A. C., Saw, R. P. M., Thompson, J. F., Stretch, J., Spillane, A., Jiang, Y., Tian, C., Agee, M., Aslibekyan, S., et al. (2022). Multi-trait genetic analysis identifies autoimmune loci associated with cutaneous melanoma. Journal of Investigative Dermatology, 142(6), 1607–1616. https://doi.org/10.1016/j.jid.2021.08.449 · DOI
  6. Liyanage, U. E., Law, M. H., Han, X., An, J., Ong, J.-S., Gharahkhani, P., Gordon, S., Neale, R. E., Olsen, C. M., MacGregor, S., & Whiteman, D. C. (2019). Combined analysis of keratinocyte cancers identifies novel genome-wide loci. Human Molecular Genetics, 28(18), 3148–3160. https://doi.org/10.1093/hmg/ddz121 · DOI
  7. Hart, P. H., & Norval, M. (2020). Are there differences in immune responses following delivery of vaccines through acutely or chronically sun-exposed compared with sun-unexposed skin? Immunology, 159(2), 133–141. https://doi.org/10.1111/imm.13128 · DOI
  8. Hart, P. H., & Norval, M. (2021). More than effects in skin: Ultraviolet radiation-induced changes in immune cells in human blood. Frontiers in Immunology, 12, 694086. https://doi.org/10.3389/fimmu.2021.694086 · DOI
  9. Hawkshaw, N. J., Pilkington, S. M., Murphy, S. A., Al-Gazaq, N., Farrar, M. D., Watson, R. E. B., Nicolaou, A., & Rhodes, L. E. (2020). UV radiation recruits CD4+GATA3+ and CD8+GATA3+ T cells while altering the lipid microenvironment following inflammatory resolution in human skin in vivo. Clinical & Translational Immunology, 9(4), e01104. https://doi.org/10.1002/cti2.1104 · DOI
  10. Byrne, S. N., Limon-Flores, A. Y., & Ullrich, S. E. (2008). Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. Journal of Immunology, 180(7), 4648–4655. https://doi.org/10.4049/jimmunol.180.7.4648 · DOI
  11. Sarchio, S. N. E., Scolyer, R. A., Beaugie, C., McDonald, D., Marsh-Wakefield, F., Halliday, G. M., & Byrne, S. N. (2014). Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer. Journal of Investigative Dermatology, 134(4), 1091–1100. https://doi.org/10.1038/jid.2013.424 · DOI
  12. Kok, L.-F., Ferguson, A. L., Marshall, J. E., Tse, B. C. Y., Halliday, G. M., & Byrne, S. N. (2020). B cell-targeted immunotherapy limits tumor growth, enhances survival, and prevents lymph node metastasis of UV-induced keratinocyte cancers in mice. Journal of Investigative Dermatology, 140(7), 1459–1463. https://doi.org/10.1016/j.jid.2019.12.018 · doi:10.1016/j.jid.2019.12.018
  13. Shime, H., Odanaka, M., Tsuiji, M., Matoba, T., Imai, M., Yasumizu, Y., Uraki, R., Minohara, K., Watanabe, M., Bonito, A. J., Fukuyama, H., Ohkura, N., Sakaguchi, S., Morita, A., & Yamazaki, S. (2020). Proenkephalin(+) regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function. Proceedings of the National Academy of Sciences of the United States of America, 117(34), 20696–20705. https://doi.org/10.1073/pnas.2000372117 · DOI
  14. Tse, B. C. Y., & Byrne, S. N. (2020). Lipids in ultraviolet radiation-induced immune modulation. Photochemical & Photobiological Sciences, 19(7), 870–878. https://doi.org/10.1039/d0pp00146e · DOI
  15. Liu, L., Awoyemi, A. A., Fahy, K. E., Thapa, P., Borchers, C., Wu, B. Y., McGlone, C. L., Schmeusser, B., Sattouf, Z., Rohan, C. A., Williams, A. R., Cates, E. E., Knisely, C., Kelly, L. E., Bihl, J. C., Cool, D. R., Sahu, R. P., Wang, J., Chen, Y., Rapp, C. M., et al. (2021). Keratinocyte-derived microvesicle particles mediate ultraviolet B radiation-induced systemic immunosuppression. Journal of Clinical Investigation, 131(10), e144963. https://doi.org/10.1172/JCI144963 · DOI
  16. Tse, B. C. Y., Ireland, R. A., Lee, J. Y., Marsh-Wakefield, F., Kok, L. F., Don, A. S., & Byrne, S. N. (2021). Exposure to systemic immunosuppressive ultraviolet radiation alters T cell recirculation through sphingosine-1-phosphate. Journal of Immunology, 207(9), 2278–2287. https://doi.org/10.4049/jimmunol.2001261 · DOI
  17. Lau, F. H., Powell, C. E., Adonecchi, G., Danos, D. M., DiNardo, A. R., Chugden, R. J., Wolf, P., & Castilla, C. F. (2022). Pilot phase results of a prospective, randomized controlled trial of narrowband ultraviolet B phototherapy in hospitalized COVID-19 patients. Experimental Dermatology, 31(7), 1109–1115. https://doi.org/10.1111/exd.14617 · DOI
  18. Maboshe, W., Macdonald, H. M., Wassall, H., Fraser, W. D., Tang, J. C. Y., Fielding, S., Barker, R. N., Vickers, M. A., Ormerod, A., & Thies, F. (2021). Low-dose vitamin D3 supplementation does not affect natural regulatory T cell population but attenuates seasonal changes in T cell-produced IFN-gamma: results from the D-SIRe2 randomized controlled trial. Frontiers in Immunology, 12, 623087. https://doi.org/10.3389/fimmu.2021.623087 · DOI
  19. Lossius, A. H., Sundnes, O., Ingham, A. C., Edslev, S. M., Bjornholt, J. V., Lilje, B., Bradley, M., Asad, S., Haraldsen, G., Skytt-Andersen, P., Holm, J. O., & Berents, T. L. (2022). Shifts in the skin microbiota after UVB treatment in adult atopic dermatitis. Dermatology, 238(1), 109–120. https://doi.org/10.1159/000515236 · DOI
  20. Bustamante, M., Hernandez-Ferrer, C., Tewari, A., Sarria, Y., Harrison, G. I., Puigdecanet, E., Nonell, L., Kang, W., Friedlander, M. R., Estivill, X., Gonzalez, J. R., Nieuwenhuijsen, M., & Young, A. R. (2020). Dose and time effects of solar-simulated ultraviolet radiation on the in vivo human skin transcriptome. British Journal of Dermatology, 182(6), 1458–1468. https://doi.org/10.1111/bjd.18527 · DOI
  21. Hart, P. H., Norval, M., Byrne, S. N., & Rhodes, L. E. (2019). Exposure to ultraviolet radiation in the modulation of human diseases. Annual Review of Pathology, 14(1), 55–81. https://doi.org/10.1146/annurev-pathmechdis-012418-012809 · DOI
  22. Sarkar, M. K., Hile, G. A., Tsoi, L. C., Xing, X., Liu, J., Liang, Y., Berthier, C. C., Swindell, W. R., Patrick, M. T., Shao, S., Tsou, P.-S., Uppala, R., Beamer, M. A., Srivastava, A., Bielas, S. L., Harms, P. W., Getsios, S., Elder, J. T., Voorhees, J. J., Gudjonsson, J. E., et al. (2018). Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Annals of Rheumatic Diseases, 77(11), 1653–1664. https://doi.org/10.1136/annrheumdis-2018-213197 · DOI · Paper page
  23. Kulkarni, N. N., Takahashi, T., Sanford, J. A., Tong, Y., Gombart, A. F., Hinds, B., Cheng, J. Y., & Gallo, R. L. (2020). Innate immune dysfunction in rosacea promotes photosensitivity and vascular adhesion molecule expression. Journal of Investigative Dermatology, 140(3), 645-655.e646. https://doi.org/10.1016/j.jid.2019.08.436 · DOI
  24. Skopelja-Gardner, S., Tai, J., Sun, X., Tanaka, L., Kuchenbecker, J. A., Snyder, J. M., Kubes, P., Mustelin, T., & Elkon, K. B. (2021). Acute skin exposure to ultraviolet light triggers neutrophil-mediated kidney inflammation. Proceedings of the National Academy of Sciences of the United States of America, 118(3), e2019097118. https://doi.org/10.1073/pnas.2019097118 · DOI
  25. Lim, H.-S., Yoon, K.-N., Chung, J. H., Lee, Y.-S., Lee, D. H., & Park, G. (2021). Chronic ultraviolet irradiation to the skin dysregulates adrenal medulla and dopamine metabolism in vivo. Antioxidants, 10(6), 920. https://doi.org/10.3390/antiox10060920 · DOI
  26. Diffey, B. (2021). Erythema and acclimatization following repeated sun exposure: a modeling study. Photochemistry and Photobiology, 97(6), 1558–1567. https://doi.org/10.1111/php.13466 · DOI
  27. Laskar, R., Ferreiro-Iglesias, A., Bishop, D. T., Iles, M. M., Kanetsky, P. A., Armstrong, B. K., Law, M. H., Goldstein, A. M., Aitken, J. F., Giles, G. G., Australian Melanoma Family Study, I., Leeds Case-Control Study, I., Robbins, H. A., & Cust, A. E. (2021). Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity. British Journal of Dermatology, 184(6), 1085–1093. https://doi.org/10.1111/bjd.19705 · DOI
  28. Ghiasvand, R., Robsahm, T. E., Green, A. C., Rueegg, C. S., Weiderpass, E., Lund, E., & Veierød, M. B. (2018). Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites. JAMA Dermatology, 155(1), 39–49. https://doi.org/10.1001/jamadermatol.2018.3964 · DOI
  29. Arnold, M., de Vries, E., Whiteman, D. C., Jemal, A., Bray, F., Parkin, D. M., & Soerjomataram, I. (2018). Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. International Journal of Cancer, 143(6), 1305–1314. https://doi.org/10.1002/ijc.31527 · DOI · Paper page
  30. O’Sullivan, D. E., Brenner, D. R., Villeneuve, P. J., Walter, S. D., Demers, P. A., Friedenreich, C. M., King, W. D., & Com, P. S. T. (2019). Estimates of the current and future burden of melanoma attributable to ultraviolet radiation in Canada. Preventive Medicine, 122, 81–90. https://doi.org/10.1016/j.ypmed.2019.03.012 · DOI
  31. Arnold, M., Kvaskoff, M., Thuret, A., Guenel, P., Bray, F., & Soerjomataram, I. (2018). Cutaneous melanoma in France in 2015 attributable to solar ultraviolet radiation and the use of sunbeds. Journal of the European Academy of Dermatology and Venereology, 32(10), 1681–1686. https://doi.org/10.1111/jdv.15022 · DOI
  32. O’Sullivan, D. E., Brenner, D. R., Villeneuve, P. J., Walter, S. D., Demers, P. A., Friedenreich, C. M., King, W. D., & Com, P. S. T. (2021). The current burden of non-melanoma skin cancer attributable to ultraviolet radiation and related risk behaviours in Canada. Cancer Causes & Control, 32(3), 279–290. https://doi.org/10.1007/s10552-020-01382-1 · DOI
  33. Little, M. P., Linet, M. S., Kimlin, M. G., Lee, T., Tatalovich, Z., Sigurdson, A. J., & Cahoon, E. K. (2019). Cumulative solar ultraviolet radiation exposure and basal cell carcinoma of the skin in a nationwide US cohort using satellite and ground-based measures. [Article]. Environmental Health, 18(1), 114. https://doi.org/10.1186/s12940-019-0536-9 · DOI
  34. Kolitz, E., Lopes, F. C. P. S., Arffa, M., Pineider, J., Bogucka, R., & Adamson, A. S. (2022). UV exposure and the risk of keratinocyte carcinoma in skin of color: a systematic review. JAMA Dermatology, 158(5), 542–546. https://doi.org/10.1001/jamadermatol.2022.0263 · DOI
  35. World Health Organisation (2021) The effect of occupational exposure to solar ultraviolet radiation on malignant skin melanoma and nonmelanoma skin cancer: a systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO
  36. Loney, T., Paulo, M. S., Modenese, A., Gobba, F., Tenkate, T., Whiteman, D. C., Green, A. C., & John, S. M. (2021). Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review. British Journal of Dermatology, 184(2), 208–218. https://doi.org/10.1111/bjd.19152 · DOI
  37. Peters, C. E., Kim, J., Song, C., Heer, E., Arrandale, V. H., Pahwa, M., Labreche, F., McLeod, C. B., Davies, H. W., Ge, C. B., & Demers, P. A. (2019). Burden of non-melanoma skin cancer attributable to occupational sun exposure in Canada. International Archives of Occupational and Environmental Health, 92(8), 1151–1157. https://doi.org/10.1007/s00420-019-01454-z · DOI
  38. Nurminen, M., & Karjalainen, A. (2001). Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland. Scandinavian Journal of Work, Environment & Health, 27(3), 161–213. pii. · DOI · Paper page
  39. Young, C., Rushton, L., British Occupational Cancer Burden Study Group. (2012). Occupational cancer in Britain. Skin cancer. British Journal of Cancer, 107(Suppl 1), S71-75. https://doi.org/10.1038/bjc.2012.120 · DOI
  40. Brand, R. M., Stottlemyer, J. M., Paglia, M. C., Carey, C. D., & Falo, L. D. (2021). Ethanol consumption synergistically increases ultraviolet radiation induced skin damage and immune dysfunction. Journal of Dermatological Science, 101(1), 40–48. https://doi.org/10.1016/j.jdermsci.2020.11.001 · DOI
  41. Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., Cust, A. E., de Vries, E., Whiteman, D. C., & Bray, F. (2022). Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatology, 158(5), 495–503. https://doi.org/10.1001/jamadermatol.2022.0160 · DOI · Paper page
  42. Urban, K., Mehrmal, S., Uppal, P., Giesey, R. L., & Delost, G. R. (2021). The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990–2017. JAAD International, 2, 98–108. https://doi.org/10.1016/j.jdin.2020.10.013 · DOI · Paper page
  43. Li, Z., Fang, Y., Chen, H., Zhang, T., Yin, X., Man, J., Yang, X., & Lu, M. (2022). Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: results from the 2019 global burden of disease study. Neoplasia, 24(1), 12–21. https://doi.org/10.1016/j.neo.2021.11.013 · DOI
  44. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492 · DOI · Paper page
  45. Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., & Bray, F. (2018). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. European Journal of Cancer, 103, 356–387. https://doi.org/10.1016/j.ejca.2018.07.005 · DOI · Paper page
  46. Lashway, S. G., Harris, R. B., Farland, L. V., O’Rourke, M. K., & Dennis, L. K. (2021). Age and cohort trends of malignant melanoma in the United States. Cancers (Basel), 13(15), 3866. https://doi.org/10.3390/cancers13153866 · DOI
  47. Aitken, J. F., Youlden, D. R., Baade, P. D., Soyer, H. P., Green, A. C., & Smithers, B. M. (2018). Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995–2014. International Journal of Cancer, 142(8), 1528–1535. https://doi.org/10.1002/ijc.31141 · DOI
  48. Eriksson, H., Nielsen, K., Vassilaki, I., Lapins, J., Mikiver, R., Lyth, J., & Isaksson, K. (2021). Trend shifts in age-specific incidence for in situ and invasive cutaneous melanoma in Sweden. Cancers (Basel), 13(11), 2838. https://doi.org/10.3390/cancers13112838 · DOI
  49. Sacchetto, L., Zanetti, R., Comber, H., Bouchardy, C., Brewster, D. H., Broganelli, P., Chirlaque, M. D., Coza, D., Galceran, J., Gavin, A., Hackl, M., Katalinic, A., Laronningen, S., Louwman, M. W. J., Morgan, E., Robsahm, T. E., Sanchez, M. J., Tryggvadottir, L., Tumino, R., Van Eycken, E., et al. (2018). Trends in incidence of thick, thin and in situ melanoma in Europe. European Journal of Cancer, 92, 108–118. https://doi.org/10.1016/j.ejca.2017.12.024 · DOI · Paper page
  50. Welch, H. G., Mazer, B. L., & Adamson, A. S. (2021). The rapid rise in cutaneous melanoma diagnoses. The New England Journal of Medicine, 384(1), 72–79. https://doi.org/10.1056/NEJMsb2019760 · DOI · Paper page
  51. Matsumoto, M., Wack, S., Weinstock, M. A., Geller, A., Wang, H., Solano, F. X., Kirkwood, J. M., & Ferris, L. K. (2022). Five-year outcomes of a melanoma screening initiative in a large health care system. JAMA Dermatology, 158(5), 504–512. https://doi.org/10.1001/jamadermatol.2022.0253 · doi:10.1001/jamadermatol.2022.0253
  52. Olsen, C. M., Thompson, J. F., Pandeya, N., & Whiteman, D. C. (2020). Evaluation of sex-specific incidence of melanoma. JAMA Dermatology, 156(5), 553–560. https://doi.org/10.1001/jamadermatol.2020.0470 · DOI
  53. Gulliver, W., Gulliver, S., Power, R. J., Penney, M., & Lane, D. (2021). The incidence of cutaneous malignant melanoma in Eastern Newfoundland and Labrador, Canada, from 2007 to 2015. Dermatology, 238(3), 527–533. https://doi.org/10.1159/000519193 · DOI
  54. Defossez, G., Uhry, Z., Delafosse, P., Dantony, E., d’Almeida, T., Plouvier, S., Bossard, N., Bouvier, A. M., Molinié, F., Woronoff, A. S., Colonna, M., Grosclaude, P., Remontet, L., & Monnereau, A. (2021). Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing. BMC Cancer, 21(1), 726. https://doi.org/10.1186/s12885-021-08261-1 · DOI
  55. Dulskas, A., Cerkauskaite, D., Vincerževskiene, I., & Urbonas, V. (2021). Trends in incidence and mortality of skin melanoma in Lithuania 1991–2015. International Journal of Environmental Research and Public Health, 18(8), 4165. https://doi.org/10.3390/ijerph18084165 · DOI
  56. Korovin, S., Fedorenko, Z., Michailovich, Y., Kukushkina, M., Sekerija, M., & Ryzhov, A. (2020). Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival. Experimental Oncology, 42(4), 324–329. https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-4.15334 · DOI
  57. Pehalova, L., Krejci, D., Snajdrova, L., & Dusek, L. (2021). Cancer incidence trends in the Czech Republic. Cancer Epidemiology, 74, 101975. https://doi.org/10.1016/j.canep.2021.101975 · doi:10.1016/j.canep.2021.101975
  58. Liszkay, G., Kiss, Z., Gyulai, R., Oláh, J., Holló, P., Emri, G., Csejtei, A., Kenessey, I., Benedek, A., Polányi, Z., Nagy-Erdei, Z., Daniel, A., Knollmajer, K., Várnai, M., Vokó, Z., Nagy, B., Rokszin, G., Fábián, I., Barcza, Z., & Polgár, C. (2020). Changing trends in melanoma incidence and decreasing melanoma mortality in Hungary between 2011 and 2019: a nationwide epidemiological study. Frontiers in Oncology, 10, 612459. https://doi.org/10.3389/fonc.2020.612459 · DOI
  59. Bai, R., Huang, H., Li, M., & Chu, M. (2021). Temporal trends in the incidence and mortality of skin malignant melanoma in China from 1990 to 2019. Journal of Oncology, 2021, 9989824. https://doi.org/10.1155/2021/9989824 · DOI
  60. Kim, T., Yoon, S., Shin, D. E., Lee, S. C., Oh, J., Lee, S. Y., Kim, D. K., Kim, S., Jung, B., Kim, M., & Lee, S. (2021). Incidence and survival rates of cutaneous melanoma in South Korea using nationwide health insurance claims data. Cancer Research and Treatment, 54(3), 937–949. https://doi.org/10.4143/crt.2021.871 · DOI
  61. Wu, Y., Wang, Y., Wang, L., Yin, P., Lin, Y., & Zhou, M. (2020). Burden of melanoma in China, 1990–2017: findings from the 2017 global burden of disease study. International Journal of Cancer, 147(3), 692–701. https://doi.org/10.1002/ijc.32764 · DOI
  62. Oh, C. C., Jin, A., & Koh, W. P. (2021). Trends of cutaneous basal cell carcinoma, squamous cell carcinoma, and melanoma among the Chinese, Malays, and Indians in Singapore from 1968–2016. JAAD International, 4, 39–45. https://doi.org/10.1016/j.jdin.2021.05.006 · DOI
  63. Chen, M. L., de Vere Hunt, I. J., John, E. M., Weinstock, M. A., Swetter, S. M., & Linos, E. (2022). Differences in thickness-specific incidence and factors associated with cutaneous melanoma in the US from 2010 to 2018. JAMA Oncology, 8(5), 755–759. https://doi.org/10.1001/jamaoncol.2022.0134 · DOI
  64. Kelm, R. C., Ali, Y., Orrell, K., Rangel, S. M., Kruse, L., Wagner, A. M., Gerami, P., West, D. P., & Nardone, B. (2021). Age and sex differences for malignant melanoma in the pediatric population-childhood versus adolescence: analysis of current nationwide data from the national cancer institute surveillance, epidemiology, and end results (SEER) program. JAMA Dermatology, 84(3), 862–864. https://doi.org/10.1016/j.jaad.2020.10.050 · DOI
  65. Heer, E. V., Harper, A. S., Sung, H., Jemal, A., & Fidler-Benaoudia, M. M. (2020). Emerging cancer incidence trends in Canada: the growing burden of young adult cancers. Cancer, 126(20), 4553–4562. https://doi.org/10.1002/cncr.33050 · DOI
  66. Bucchi, L., Mancini, S., Crocetti, E., Dal Maso, L., Baldacchini, F., Vattiato, R., Giuliani, O., Ravaioli, A., Caldarella, A., Carrozzi, G., Ferretti, S., Filiberti, R. A., Fusco, M., Gatti, L., Gili, A., Magoni, M., Mangone, L., Mazzoleni, G., Michiara, M., Panato, C., et al. (2021). Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy. International Journal of Cancer, 148(4), 835–844. https://doi.org/10.1002/ijc.33259 · DOI
  67. Memon, A., Banniser, P., Rogers, I., Sundin, J., Al-Ayadhy, B., James, P. W., & McNally, R. J. Q. (2021). Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: an analysis of the national cancer registration data by age, gender and anatomical site, 1981–2018. The Lancet Regional Health Europe, 2, 100024. · DOI
  68. Rousi, E. K., Kallionpää, R. A., Kallionpää, R. E., Juteau, S. M., Talve, L. A. I., Hernberg, M. M., Vihinen, P. P., Kähäri, V. M., & Koskivuo, I. O. (2022). Increased incidence of melanoma in children and adolescents in Finland in 1990–2014: nationwide re-evaluation of histopathological characteristics. Annals of Medicine, 54(1), 244–252. https://doi.org/10.1080/07853890.2022.2026001 · DOI
  69. Bernhard, G. H., Neale, R. E., Barnes, P. W., Neale, P. J., Zepp, R. G., Wilson, S. R., Andrady, A. L., Bais, A. F., McKenzie, R. L., Aucamp, P. J., Young, P. J., Liley, J. B., Lucas, R. M., Yazar, S., Rhodes, L. E., Byrne, S. N., Hollestein, L. M., Olsen, C. M., Young, A. R., Robson, T. M., et al. (2020). Environmental effects of stratospheric ozone depletion, UV radiation and interactions with climate change: UNEP environmental effects assessment panel, update 2019. Photochemical & Photobiological Sciences, 19, 542–584. https://doi.org/10.1039/d0pp90011g · DOI · Paper page
  70. Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021). Cancer statistics for the year 2020: an overview. International Journal of Cancer, 149(4), 778–789. https://doi.org/10.1002/ijc.33588 · DOI · Paper page
  71. Berk-Krauss, J., Stein, J. A., Weber, J., Polsky, D., & Geller, A. C. (2020). New systematic therapies and trends in cutaneous melanoma deaths among US Whites, 1986–2016. American Journal of Public Health, 110(5), 731–733. https://doi.org/10.2105/AJPH.2020.305567 · DOI · Paper page
  72. Yang, D. D., Salciccioli, J. D., Marshall, D. C., Sheri, A., & Shalhoub, J. (2020). Trends in malignant melanoma mortality in 31 countries from 1985 to 2015. British Journal of Dermatology, 183(6), 1056–1064. https://doi.org/10.1111/bjd.19010 · DOI
  73. Gutierrez-Gonzalez, E., Lopez-Abente, G., Aragones, N., Pollan, M., Pastor-Barriuso, R., Sanchez, M. J., & Perez-Gomez, B. (2019). Trends in mortality from cutaneous malignant melanoma in Spain (1982–2016): sex-specific age-cohort-period effects. Journal of the European Academy of Dermatology and Venereology, 33(8), 1522–1528. https://doi.org/10.1111/jdv.15565 · DOI
  74. van Niekerk, C. C., Groenewoud, H. M. M., & Verbeek, A. L. M. (2021). Trends and projections in cutaneous melanoma death in the Netherlands from 1950 to 2045. Medicine Open, 100(48), e27784.
  75. Nader Marta, G., Munhoz, R. R., Teixeira, M. P., Waldvogel, B. C., Pires de Camargo, V., Feher, O., & Sanches, J. A. (2020). Trends in melanoma mortality in Brazil: a registry-based study. JCO Global Oncology, 6, 1766–1771. https://doi.org/10.1200/go.20.00426 · DOI
  76. Olsen, C. M., Pandeya, N., & Whiteman, D. C. (2021). International increases in Merkel cell carcinoma incidence rates between 1997 and 2016. Journal of Investigative Dermatology, 141(11), 2596–2601. https://doi.org/10.1016/j.jid.2021.04.007 · DOI
  77. de Melo, A. C., & Santos Thuler, L. C. (2021). Trends in the incidence and morbidity of Merkel cell carcinoma in Brazil. Future Oncology, 17(22), 2857–2865. https://doi.org/10.2217/fon-2020-1313 · DOI
  78. Stang, A., Becker, J. C., Nghiem, P., & Ferlay, J. (2018). The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment. European Journal of Cancer, 94, 47–60. https://doi.org/10.1016/j.ejca.2018.02.003 · DOI
  79. Jacobs, D., Huang, H., Olino, K., Weiss, S., Kluger, H., Judson, B. L., & Zhang, Y. (2021). Assessment of age, period, and birth cohort effects and trends in Merkel cell carcinoma incidence in the United States. JAMA Dermatology, 157(1), 59–65. https://doi.org/10.1001/jamadermatol.2020.4102 · DOI
  80. Goh, G., Walradt, T., Markarov, V., Blom, A., Riaz, N., Doumani, R., Stafstrom, K., Moshiri, A., Yelistratova, L., Levinsohn, J., Chan, T. A., Nghiem, P., Lifton, R. P., & Choi, J. (2016). Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget, 7(3), 3403–3415. https://doi.org/10.18632/oncotarget.6494 · DOI · Paper page
  81. Mokánszki, A., Méhes, G., Csoma, S. L., Kollár, S., & Chang Chien, Y. C. (2021). Molecular profiling of Merkel cell polyomavirus-associated Merkel cell carcinoma and cutaneous melanoma. Diagnostics (Basel), 11(2), 212. https://doi.org/10.3390/diagnostics11020212 · doi:10.3390/diagnostics11020212
  82. Harms, K. L., Healy, M. A., Nghiem, P., Sober, A. J., Johnson, T. M., Bichakjian, C. K., & Wong, S. L. (2016). Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Annals of Surgical Oncology, 23(11), 3564–3571. https://doi.org/10.1245/s10434-016-5266-4 · DOI · Paper page
  83. D’Angelo, S. P., Bhatia, S., Brohl, A. S., Hamid, O., Mehnert, J. M., Terheyden, P., Shih, K. C., Brownell, I., Lebbé, C., Lewis, K. D., Linette, G. P., Milella, M., Georges, S., Shah, P., Ellers-Lenz, B., Bajars, M., Güzel, G., & Nghiem, P. T. (2020). Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial. Journal for Immunotherapy of Cancer, 8(1), e000674. https://doi.org/10.1136/jitc-2020-000674 · DOI · Paper page
  84. Chang, W. C., Lin, A. Y., Hsu, J. C., Wu, C. E., Goh, C., Chou, P., Kuo, K., Chang, A., & Palencia, R. (2021). A cost-utility analysis of avelumab for metastatic Merkel cell carcinoma in Taiwan. Cancer Reports, 4(6), e1399. https://doi.org/10.1002/cnr2.1399 · DOI
  85. Garza-Davila, V. F., Valdespino-Valdes, J., Barrera, F. J., Ocampo-Candiani, J., & Garza-Rodríguez, V. (2022). Clinical impact of immunotherapy in Merkel cell carcinoma patients: a systematic review and meta-analysis. JAMA Dermatology, 87(1), 121–130. https://doi.org/10.1016/j.jaad.2021.04.024 · DOI
  86. Venables, Z. C., Nijsten, T., Wong, K. F., Autier, P., Broggio, J., Deas, A., Harwood, C. A., Hollestein, L. M., Langan, S. M., Morgan, E., Proby, C. M., Rashbass, J., & Leigh, I. M. (2019). Epidemiology of basal and cutaneous squamous cell carcinoma in the UK 2013–15: a cohort study. [Article in Press]. British Journal of Dermatology, 181(3), 474–482. https://doi.org/10.1111/bjd.17873 · DOI · Paper page
  87. Tokez, S., Hollestein, L., Louwman, M., Nijsten, T., & Wakkee, M. (2020). Incidence of multiple vs first cutaneous squamous cell carcinoma on a nationwide scale and estimation of future incidences of cutaneous squamous cell carcinoma. JAMA Dermatology, 156(12), 1300–1306. https://doi.org/10.1001/jamadermatol.2020.3677 · DOI
  88. Global Burden of Disease 2016 Cancer Collaboration. (2021). Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncology, 8(2), 420. https://doi.org/10.1001/jamaoncol.2021.6987 · DOI · Paper page
  89. Zhang, W., Zeng, W., Jiang, A., He, Z., Shen, X., Dong, X., Feng, J., & Lu, H. (2021). Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Cancer Medicine, 10(14), 4905–4922. https://doi.org/10.1002/cam4.4046 · DOI · Paper page
  90. Pondicherry, A., Martin, R., Meredith, I., Rolfe, J., Emanuel, P., & Elwood, M. (2018). The burden of non-melanoma skin cancers in Auckland, New Zealand. [Article]. Australasian Journal of Dermatology, 59(3), 210–213. https://doi.org/10.1111/ajd.12751 · DOI
  91. Pandeya, N., Olsen, C. M., & Whiteman, D. C. (2017). The incidence and multiplicity rates of keratinocyte cancers in Australia. Medical Journal of Australia, 207(8), 339–343. https://doi.org/10.5694/mja17.00284. pii. · DOI
  92. Staples, M. P., Elwood, M., Burton, R. C., Williams, J. L., Marks, R., & Giles, G. G. (2006). Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Medical Journal of Australia, 184(1), 6–10. pii. · DOI · Paper page
  93. Adelson, P., Sharplin, G. R., Roder, D. M., & Eckert, M. (2018). Keratinocyte cancers in South Australia: incidence, geographical variability and service trends. [Article]. Australian and New Zealand Journal of Public Health, 42(4), 329–333. https://doi.org/10.1111/1753-6405.12806 · DOI
  94. Adalsteinsson, J. A., Ratner, D., Olafsdottir, E., Grant-Kels, J., Ungar, J., Silverberg, J. I., Kristjansson, A. K., Jonasson, J. G., & Tryggvadottir, L. (2020). Basal cell carcinoma: an emerging epidemic in women in Iceland. British Journal of Dermatology, 183(5), 847–856. https://doi.org/10.1111/bjd.18937 · DOI
  95. Adalsteinsson, J. A., Olafsdottir, E., Ratner, D., Waldman, R., Feng, H., Ungar, J., Silverberg, J. I., Kristjansson, A. K., Jonasson, J. G., & Tryggvadottir, L. (2021). Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland. British Journal of Dermatology, 185(3), 537–547. https://doi.org/10.1111/bjd.19879 · DOI
  96. Ilić, D., Videnović, G., Kozomara, R., Radaković, S. S., Vlahović, Z., Matvijenko, V., & Živković, S. (2020). Non-melanoma skin cancers in Serbia (1999–2015)—the need for national prevention and control strategy. [Article]. Vojnosanitetski Pregled, 77(11), 1154–1160. https://doi.org/10.2298/vsp181112201i · DOI
  97. Mirza, F. N., Yumeen, S., & Walter, F. M. (2021). The epidemiology of malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK from 2004 to 2014: a population-based cohort analysis using the Clinical Practice Research Datalink. [Article]. British Journal of Dermatology, 184(2), 365–367. https://doi.org/10.1111/bjd.19542 · doi:10.1111/bjd.19542
  98. Aggarwal, P., Knabel, P., & Fleischer, A. B., Jr. (2021). United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. JAMA Dermatology, 85(2), 388–395. https://doi.org/10.1016/j.jaad.2021.03.109 · DOI · Paper page
  99. Kwiatkowska, M., Ahmed, S., Ardern-Jones, M. R., Bhatti, L. A., Bleiker, T. O., Gavin, A., Hussain, S., Huws, D. W., Irvine, L., Langan, S. M., Millington, G. W. M., Mitchell, H., Murphy, R., Paley, L., Proby, C. M., Thomson, C. S., Thomas, R., Turner, C., Vernon, S., & Venables, Z. C. (2022). A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the UK 2013–2018. [Letter]. British Journal of Dermatology, 186(2), 367–369. https://doi.org/10.1111/bjd.20764 · doi:10.1111/bjd.20764
  100. Olsen, C. M., Pandeya, N., Green, A. C., Ragaini, B. S., Venn, A. J., & Whiteman, D. C. (2022). Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk. Public Health Research and Practice, 32(1), e3212203. https://doi.org/10.17061/phrp3212203 · DOI
  101. Dziunycz, P. J., Schuller, E., & Hofbauer, G. F. L. (2018). Prevalence of actinic keratosis in patients attending general practitioners in Switzerland. [Article]. Dermatology, 234(5–6), 186–191. https://doi.org/10.1159/000491820 · DOI
  102. Ferrándiz-Pulido, C., Lera-Imbuluzqueta, M., Ferrándiz, C., & Plazas-Fernandez, M. J. (2018). Prevalence of actinic keratosis in different regions of Spain: the EPIQA Study. [Article]. Actas Dermo-Sifiliográficas, 109(1), 83–86. https://doi.org/10.1016/j.adengl.2017.05.023 · doi:10.1016/j.adengl.2017.05.023
  103. Tokez, S., Wakkee, M., Louwman, M., Noels, E., Nijsten, T., & Hollestein, L. (2020). Assessment of cutaneous squamous cell carcinoma (cSCC) in situ incidence and the risk of developing invasive cSCC in patients with prior cSCC in situ vs the general population in the Netherlands, 1989–2017. JAMA Dermatology, 156(9), 973–981. https://doi.org/10.1001/jamadermatol.2020.1988 · DOI
  104. Friman, T. K., Jäämaa-Holmberg, S., Åberg, F., Helanterä, I., Halme, M., Pentikäinen, M. O., Nordin, A., Lemström, K. B., Jahnukainen, T., Räty, R., & Salmela, B. (2022). Cancer risk and mortality after solid organ transplantation: a population-based 30-year cohort study in Finland. International Journal of Cancer, 150(11), 1779–1791. https://doi.org/10.1002/ijc.33934 · DOI
  105. Poizot-Martin, I., Lions, C., Delpierre, C., Makinson, A., Allavena, C., Fresard, A., Brégigeon, S., Rojas, T. R., & Delobel, P. (2022). Prevalence and spectrum of second primary malignancies among people living with HIV in the French Dat’AIDS Cohort. Cancers (Basel), 14(2), 401. https://doi.org/10.3390/cancers14020401 · doi:10.3390/cancers14020401
  106. Yuan, T., Hu, Y., Zhou, X., Yang, L., Wang, H., Li, L., Wang, J., Qian, H.-Z., Clifford, G. M., & Zou, H. (2022). Incidence and mortality of non-AIDS-defining cancers among people living with HIV: A systematic review and meta-analysis. eClinicalMedicine, 52, 101613. https://doi.org/10.1016/j.eclinm.2022.101613 · DOI
  107. D’Arcy, M. E., Beachler, D. C., Pfeiffer, R. M., Curtis, J. R., Mariette, X., Seror, R., Mahale, P., Rivera, D. R., Yanik, E. L., & Engels, E. A. (2021). Tumor necrosis factor inhibitors and the risk of cancer among older Americans with rheumatoid arthritis. Cancer Epidemiology, Biomarkers & Prevention, 30(11), 2059–2067. https://doi.org/10.1158/1055-9965.EPI-21-0125 · DOI
  108. Turk, T., Saad, A. M., Al-Husseini, M. J., & Gad, M. M. (2020). The risk of melanoma in patients with chronic lymphocytic leukemia: a population-based study. Current Problems in Cancer, 44(2), 100511–100511. https://doi.org/10.1016/j.currproblcancer.2019.100511 · DOI
  109. Plasmeijer, E., Jiyad, Z., Way, M., Marquart, L., Miura, K., Campbell, S., Isbel, N., Fawcett, J., Ferguson, L. E., Davis, M., Whiteman, D. C., Soyer, H. P., O’Rourke, P., & Green, A. C. (2019). Extreme incidence of skin cancer in kidney and liver yransplant recipients living with high sun exposure. Acta Dermato-Venereologica, 99(10), 929–930. https://doi.org/10.2340/00015555-3234 · DOI
  110. Ortega-Ortega, M., Hanly, P., Pearce, A., Soerjomataram, I., & Sharp, L. (2021). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer, 150(4), 580–593. https://doi.org/10.1002/ijc.33826 · DOI
  111. Yang, J. J., Maloney, N. J., Cheng, K., & Bach, D. Q. (2021). Financial burden in US patients with melanoma from 1997 to 2015: racial disparities, trends, and predictors of high expenditures. JAMA Dermatology, 84(3), 819–821. https://doi.org/10.1016/j.jaad.2020.07.051 · doi:10.1016/j.jaad.2020.07.051
  112. Noels, E., Hollestein, L., Luijkx, K., Louwman, M., de Uyl-de Groot, C., van den Bos, R., van der Veldt, A., Grunhagen, D., & Wakkee, M. (2020). Increasing costs of skin cancer due to increasing incidence and introduction of pharmaceuticals, 2007–2017. Acta Dermato-Venereologica, 100(10), adv00147. https://doi.org/10.2340/00015555-3463 · DOI
  113. Grange, F., Mohr, P., Harries, M., Ehness, R., Benjamin, L., Siakpere, O., Barth, J., Stapelkamp, C., Pfersch, S., McLeod, L. D., Kaye, J. A., Wolowacz, S., & Kontoudis, I. (2017). Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study). Melanoma Research, 27(6), 607–618. https://doi.org/10.1097/cmr.0000000000000372 · DOI
  114. Fernandes, J., Bregman, B., Combemale, P., Amaz, C., de Leotoing, L., Vainchtock, A., & Gaudin, A. F. (2017). Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment). BMC Health Services Research, 17(1), 542. https://doi.org/10.1186/s12913-017-2472-0 · DOI
  115. Copley-Merriman, C., Stevinson, K., Liu, F. X., Wang, J., Mauskopf, J., Zimovetz, E. A., & Chmielowski, B. (2018). Direct costs associated with adverse events of systemic therapies for advanced melanoma: systematic literature review. Medicine (Baltimore), 97(31), e11736. https://doi.org/10.1097/md.0000000000011736 · doi:10.1097/md.0000000000011736
  116. Krensel, M., Schafer, I., & Augustin, M. (2019). Cost-of-illness of melanoma in Europe—a modelling approach. Journal of the European Academy of Dermatology and Venereology, 33(Suppl 2), 34–45. https://doi.org/10.1111/jdv.15308 · DOI
  117. Gordon, L. G., Leung, W., Johns, R., McNoe, B., Lindsay, D., Merollini, K. M. D., Elliott, T. M., Neale, R. E., Olsen, C. M., Pandeya, N., & Whiteman, D. C. (2022). Estimated healthcare costs of melanoma and keratinocyte skin cancers in Australia and Aotearoa New Zealand in 2021. International Journal of Environmental Research and Public Health, 19(6), 3178. https://doi.org/10.3390/ijerph19063178 · DOI
  118. Luke, J. J., Ascierto, P. A., Carlino, M. S., Gershenwald, J. E., Grob, J.-J., Hauschild, A., Kirkwood, J. M., Long, G., Mohr, P., Robert, C., Ross, M., Scolyer, R. A., Yoon, C. H., Poklepovic, A., Rutkowski, P., Anderson, J. R., Ahsan, S., Ibrahim, N., & Eggermont, A. M. M. (2020). KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncology, 16(3), 4429–4438. https://doi.org/10.2217/fon-2019-0666 · DOI
  119. Anderson, A., Matsumoto, M., Secrest, A., Saul, M. I., Ho, J., & Ferris, L. K. (2021). Cost of treatment of benign and premalignant lesions during skin cancer screening. JAMA Dermatology, 157(7), 876–879. https://doi.org/10.1001/jamadermatol.2021.1953 · doi:10.1001/jamadermatol.2021.1953
  120. Gordon, L., Olsen, C., Whiteman, D. C., Elliott, T. M., Janda, M., & Green, A. (2020). Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study. BMJ Open, 10(2), e034388. https://doi.org/10.1136/bmjopen-2019-034388 · DOI
  121. van der Pols, J. C., Williams, G. M., Neale, R. E., Clavarino, A., & Green, A. C. (2006). Long-term increase in sunscreen use in an Australian community after a skin cancer prevention trial. Preventive Medicine, 42(3), 171–176. https://doi.org/10.1016/j.ypmed.2005.10.007 · DOI
  122. Janda, M., Youl, P., Neale, R., Aitken, J., Whiteman, D., Gordon, L., & Baade, P. (2014). Clinical skin examination outcomes after a video-based behavioral intervention: analysis from a randomized clinical trial. JAMA Dermatology, 150(4), 372–379. https://doi.org/10.1001/jamadermatol.2013.9313 · DOI
  123. Mofidi, A., Tompa, E., Spencer, J., Kalcevich, C., Peters, C. E., Kim, J., Song, C., Mortazavi, S. B., & Demers, P. A. (2018). The economic burden of occupational non-melanoma skin cancer due to solar radiation. Journal of Occupational and Environmental Hygiene, 15(6), 481–491. https://doi.org/10.1080/15459624.2018.1447118 · DOI
  124. Mofidi, A., Tompa, E., Song, C., Tenkate, T., Arrandale, V., Jardine, J. K., Davies, H., & Demers, P. A. (2021). Economic evaluation of interventions to reduce solar ultraviolet radiation (UVR) exposure among construction workers. Journal of Occupational and Environmental Hygiene, 18(6), 250–264. https://doi.org/10.1080/15459624.2021.1910278 · doi:10.1080/15459624.2021.1910278
  125. Yoon, J., Phibbs, C. S., Chow, A., & Weinstock, M. A. (2018). Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis. [Article]. JAMA Dermatology, 79(3), 501-507.e502. https://doi.org/10.1016/j.jaad.2018.02.058 · DOI
  126. Fitzpatrick, T. B. (1988). The validity and practicality of sun-reactive skin types I through VI. Archives of Dermatology, 124(6), 869–871. https://doi.org/10.1001/archderm.124.6.869 · DOI · Paper page
  127. Olsen, C. M., Pandeya, N., Law, M. H., MacGregor, S., Iles, M. M., Thompson, B. S., Green, A. C., Neale, R. E., & Whiteman, D. C. (2020). Does polygenic risk influence associations between sun exposure and melanoma? A prospective cohort analysis. British Journal of Dermatology, 183(2), 303–310. https://doi.org/10.1111/bjd.18703 · DOI
  128. Savoye, I., Olsen, C. M., Whiteman, D. C., Bijon, A., Wald, L., Dartois, L., Clavel-Chapelon, F., Boutron-Ruault, M.-C., & Kvaskoff, M. (2018). Patterns of ultraviolet radiation exposure and skin cancer risk: the E3N-SunExp Study. Journal of Epidemiology, 28(1), 27–33. https://doi.org/10.2188/jea.JE20160166 · DOI
  129. Kawai, K., VoPham, T., Drucker, A., Curhan, S. G., & Curhan, G. C. (2020). Ultraviolet radiation exposure and the risk of Herpes zoster in three prospective cohort studies. Mayo Clinic Proceedings, 95(2), 283–292. https://doi.org/10.1016/j.mayocp.2019.08.022 · DOI
  130. Tripathi, R., Mazmudar, R. S., Knusel, K. D., Ezaldein, H. H., Bordeaux, J. S., & Scott, J. F. (2021). Trends in emergency department visits due to sunburn and factors associated with severe sunburns in the United States. Archives of Dermatological Research, 313(2), 79–88. https://doi.org/10.1007/s00403-020-02073-2 · DOI
  131. Holman, D. M., Ding, H., Berkowitz, Z., Hartman, A. M., & Perna, F. M. (2019). Sunburn prevalence among US adults, National Health Interview Survey 2005, 2010, and 2015. JAMA Dermatology, 80(3), 817–820. https://doi.org/10.1016/j.jaad.2018.10.044 · DOI
  132. Wei, G., Farooq, J., Castelo-Soccio, L., & Mhaskar, R. (2021). Correlates between physical activity and sunburn prevalence among a nationally representative sample of US high school students, 2015–2017. Journal of Physical Activity and Health, 18(9), 1113–1119. https://doi.org/10.1123/jpah.2020-0711 · DOI
  133. Blazquez-Sanchez, N., Rivas-Ruiz, F., Bueno-Fernandez, S., Fernandez-Morano, M. T., Arias-Santiago, S., Rodriguez-Martinez, A., DeCastro-Maqueda, G., & DeTroya-Martin, M. (2021). Photoprotection habits, attitudes and knowledge among school communities in the Costa del sol (Spain). European Journal of Public Health, 31(3), 508–514. https://doi.org/10.1093/eurpub/ckab010 · DOI
  134. Goerig, T., Soedel, C., Pfahlberg, A. B., Gefeller, O., Breitbart, E. W., & Diehl, K. (2021). Sun protection and sunburn in children aged 1–10 years in Germany: prevalence and determinants. Children (Basel), 8(8), 668. https://doi.org/10.3390/children8080668 · DOI
  135. Tabbakh, T., Volkov, A., Wakefield, M., & Dobbinson, S. (2019). Implementation of the SunSmart program and population sun protection behaviour in Melbourne, Australia: results from cross-sectional summer surveys from 1987 to 2017. PLoS Medicine, 16(10), e1002932–e1002932. https://doi.org/10.1371/journal.pmed.1002932 · DOI
  136. Liew, A. Y. S., & Cust, A. E. (2021). Changes in sun protection behaviours, sun exposure and shade availability among adults, children and adolescents in New South Wales, 2003–2016. Australian and New Zealand Journal of Public Health, 45(5), 462–468. https://doi.org/10.1111/1753-6405.13112 · DOI
  137. Køster, B., Meyer, M., Andersson, T., Engholm, G., & Dalum, P. (2018). Development in sunburn 2007–2015 and skin cancer projections 2007–2040 of campaign results in the Danish population. Medicine (Baltimore), 97(41), e12738–e12738. https://doi.org/10.1097/MD.0000000000012738 · DOI
  138. Lacson, J. C. A., Zamani, S. A., Froes, L. A. R., Jr., Mitra, N., Qian, L., Doyle, S. H., Azizi, E., Balestrini, C., Bishop, D. T., Bruno, W., Carlos-Ortega, B., Cuellar, F., Cust, A. E., Elder, D. E., Gerdes, A.-M., Ghiorzo, P., Grazziotin, T. C., Gruis, N. A., Hansson, J., Hocevar, M., et al. (2021). Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families. BMC Public Health, 21(1), 692–692. https://doi.org/10.1186/s12889-021-10424-5 · DOI
  139. Shih, B. B., Allan, D., de Gruijl, F. R., & Rhodes, L. E. (2015). Robust detection of minimal sunburn in pigmented skin by 785 nm laser speckle contrast imaging of blood flux. Journal of Investigative Dermatology, 135(4), 1197–1199. https://doi.org/10.1038/jid.2014.507 · DOI
  140. Calderón, T. A., Bleakley, A., Jordan, A. B., Lazovich, D., & Glanz, K. (2019). Correlates of sun protection behaviors in racially and ethnically diverse US adults. Preventive Medicine Reports, 13, 346–353. https://doi.org/10.1016/j.pmedr.2018.12.006 · DOI · Paper page
  141. Bello, O., Sudhoff, H., & Goon, P. (2021). Sunburn prevalence is underestimated in UK-based people of African ancestry. Clinical, Cosmetic and Investigational Dermatology, 14, 1791–1797. https://doi.org/10.2147/CCID.S334574 · DOI
  142. Rhodes, L. E., Bock, M., Soe Janssens, A., Ling, T. C., Anastasopoulou, L., Antoniou, C., Aubin, F., Bruckner, T., Faivre, B., Gibbs, N. K., Jansen, C., Pavel, S., Stratigos, A. J., de Gruijl, F. R., & Diepgen, T. L. (2010). Polymorphic light eruption occurs in 18% of Europeans and does not show higher prevalence with increasing latitude: Multicenter survey of 6,895 individuals residing from the Mediterranean to Scandinavia. Journal of Investigative Dermatology, 130(2), 626–628. https://doi.org/10.1038/jid.2009.250 · doi:10.1038/jid.2009.250
  143. Gutierrez, D., Gaulding, J. V., Motta Beltran, A. F., Lim, H. W., & Pritchett, E. N. (2018). Photodermatoses in skin of colour. Journal of the European Academy of Dermatology and Venereology, 32(11), 1879–1886. https://doi.org/10.1111/jdv.15115 · DOI
  144. Gether, L., Overgaard, L. K., Egeberg, A., & Thyssen, J. P. (2018). Incidence and prevalence of rosacea: a systematic review and meta-analysis. British Journal of Dermatology, 179(2), 282–289. https://doi.org/10.1111/bjd.16481 · DOI · Paper page
  145. Rutter, K. J., Ashraf, I., Cordingley, L., & Rhodes, L. E. (2020). Quality of life and psychological impact in the photodermatoses: a systematic review. British Journal of Dermatology, 182(5), 1092–1102. https://doi.org/10.1111/bjd.18326 · DOI
  146. Hofmann, G. A., Gradl, G., Schulz, M., Haidinger, G., Tanew, A., & Weber, B. (2020). The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature. Journal of the European Academy of Dermatology and Venereology, 34(3), 589–600. https://doi.org/10.1111/jdv.15952 · DOI
  147. Nakao, S., Hatahira, H., Sasaoka, S., Hasegawa, S., Motooka, Y., Ueda, N., Abe, J., Fukuda, A., Naganuma, M., Kanoh, H., Seishima, M., Ishiguro, M., Kinosada, Y., & Nakamura, M. (2017). Evaluation of drug-induced photosensitivity using the Japanese adverse drug event report (JADER) Database. Biological and Pharmaceutical Bulletin, 40(12), 2158–2165. https://doi.org/10.1248/bpb.b17-00561 · DOI
  148. Kim, W. B., Shelley, A. J., Novice, K., Joo, J., Lim, H. W., & Glassman, S. J. (2018). Drug-induced phototoxicity: a systematic review. JAMA Dermatology, 79(6), 1069–1075. https://doi.org/10.1016/j.jaad.2018.06.061 · DOI
  149. Alrashidi, A., Rhodes, L. E., Sharif, J. C. H., Kreeshan, F. C., Farrar, M. D., & Ahad, T. (2020). Systemic drug photosensitivity—culprits, impact and investigation in 122 patients. Photodermatology, Photoimmunology & Photomedicine, 36(6), 441–451. https://doi.org/10.1111/phpp.12583 · DOI
  150. Pedersen, S. A., Gaist, D., Schmidt, S. A. J., Holmich, L. R., Friis, S., & Pottegard, A. (2018). Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark. JAMA Dermatology, 78(4), 673-681 e679. https://doi.org/10.1016/j.jaad.2017.11.042 · DOI · Paper page
  151. Pottegård, A., Pedersen, S. A., Schmidt, S. A. J., Lee, C.-N., Hsu, C.-K., Liao, T.-C., Shao, S.-C., & Lai, E.C.-C. (2019). Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study. British Journal of Cancer, 121(11), 973–978. https://doi.org/10.1038/s41416-019-0613-4 · DOI
  152. Gallelli, L., Cione, E., Siniscalchi, A., Vasta, G., Guerra, A., Scaramuzzino, A., Longo, L., Muraca, L., De Sarro, G., Leuzzi, G., Gerace, A., Scuteri, A., Vasapollo, P., Natale, V., Zampogna, S., & Luciani, F. (2021). Is there a link between non-melanoma skin cancer and hydrochlorothiazide? Current Drug Safety, 17(3), 211–216. https://doi.org/10.2174/1574886316666211103164412 · DOI
  153. Daniels, B., Pearson, S. A., Vajdic, C. M., Pottegård, A., Buckley, N. A., & Zoega, H. (2020). Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: a population-based case-control study. Basic and Clinical Pharmacology and Toxicology, 127(4), 320–328. https://doi.org/10.1111/bcpt.13463 · DOI
  154. Bendinelli, B., Masala, G., Garamella, G., Palli, D., & Caini, S. (2019). Do thiazide diuretics increase the risk of skin cancer? A critical review of the scientific evidence and updated meta-analysis. Current Cardiology Reports, 21(9), 92. https://doi.org/10.1007/s11886-019-1183-z · DOI
  155. Williams, N. M., Vincent, L. T., Rodriguez, G. A., & Nouri, K. (2020). Antihypertensives and melanoma: an updated review. Pigment Cell & Melanoma Research, 33(6), 806–813. https://doi.org/10.1111/pcmr.12918 · DOI
  156. Hatsusaka, N., Seki, Y., Mita, N., Ukai, Y., Miyashita, H., Kubo, E., Sliney, D., & Sasaki, H. (2021). UV Index does not predict ocular ultraviolet exposure. Translational Vision Science & Technology, 10(7), 1. https://doi.org/10.1167/tvst.10.7.1 · DOI
  157. Marro, M., Moccozet, L., & Vernez, D. (2022). Assessing human eye exposure to UV light: a narrative review. Frontiers in Public Health, 10, 900979–900979. https://doi.org/10.3389/fpubh.2022.900979 · doi:10.3389/fpubh.2022.900979
  158. Lanca, C., Teo, A., Vivagandan, A., Htoon, H. M., Najjar, R. P., Spiegel, D. P., Pu, S.-H., & Saw, S.-M. (2019). The effects of different outdoor environments, sunglasses and hats on light levels: implications for myopia prevention. Translational Vision Science & Technology, 8(4), 7–7. https://doi.org/10.1167/tvst.8.4.7 · DOI
  159. Backes, C., Religi, A., Moccozet, L., Behar-Cohen, F., Vuilleumier, L., Bulliard, J. L., & Vernez, D. (2019). Sun exposure to the eyes: predicted UV protection effectiveness of various sunglasses. Journal of Exposure Science & Environmental Epidemiology, 29(6), 753–764. https://doi.org/10.1038/s41370-018-0087-0 · DOI
  160. Rabbetts, R., & Sliney, D. (2019). Technical report: solar ultraviolet protection from sunglasses. Optometry and Vision Science, 96(7), 523–530. https://doi.org/10.1097/OPX.0000000000001397 · DOI
  161. Lofgren, S. (2017). Solar ultraviolet radiation cataract. Experimental Eye Research, 156, 112–116. https://doi.org/10.1016/j.exer.2016.05.026 · doi:10.1016/j.exer.2016.05.026
  162. Cheng, C.-Y., Wang, N., Wong, T. Y., Congdon, N., He, M., Wang, Y. X., Braithwaite, T., Casson, R. J., Cicinelli, M. V., Das, A., Flaxman, S. R., Jonas, J. B., Keeffe, J. E., Kempen, J. H., Leasher, J., Limburg, H., Naidoo, K., Pesudovs, K., Resnikoff, S., Silvester, A. J., et al. (2020). Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections. British Journal of Ophthalmology, 104(5), 616–622. https://doi.org/10.1136/bjophthalmol-2018-313308 · DOI
  163. Kahloun, R., Khairallah, M., Resnikoff, S., Cicinelli, M. V., Flaxman, S. R., Das, A., Jonas, J. B., Keeffe, J. E., Kempen, J. H., Leasher, J., Limburg, H., Naidoo, K., Pesudovs, K., Silvester, A. J., Tahhan, N., Taylor, H. R., Wong, T. Y., Bourne, R. R. A., Vision Loss Expert Group of the Global Burden of Disease, S. (2019). Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections. British Journal of Ophthalmology, 103(7), 863–870. https://doi.org/10.1136/bjophthalmol-2018-312068 · DOI
  164. Keeffe, J. E., Casson, R. J., Pesudovs, K., Taylor, H. R., Cicinelli, M. V., Das, A., Flaxman, S. R., Jonas, J. B., Kempen, J. H., Leasher, J., Limburg, H., Naidoo, K., Silvester, A. J., Stevens, G. A., Tahhan, N., Wong, T. Y., Resnikoff, S., & Bourne, R. R. A. (2019). Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections. British Journal of Ophthalmology, 103(7), 878–884. https://doi.org/10.1136/bjophthalmol-2018-311946 · DOI
  165. Leasher, J. L., Braithwaite, T., Furtado, J. M., Flaxman, S. R., Lansingh, V. C., Silva, J. C., Resnikoff, S., Taylor, H. R., Bourne, R. R. A., Vision Loss Expert Group of the Global Burden of Disease, S. (2019). Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections. British Journal of Ophthalmology, 103(7), 885–893. https://doi.org/10.1136/bjophthalmol-2017-311746 · DOI
  166. Naidoo, K., Kempen, J. H., Gichuhi, S., Braithwaite, T., Casson, R. J., Cicinelli, M. V., Das, A., Flaxman, S. R., Jonas, J. B., Keeffe, J. E., Leasher, J., Limburg, H., Pesudovs, K., Resnikoff, S., Silvester, A. J., Tahhan, N., Taylor, H. R., Wong, T. Y., Bourne, R. R. A., Vision Loss Expert Group of the Global Burden of Disease, S. (2020). Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections. British Journal of Ophthalmology, 104(12), 1658–1668. https://doi.org/10.1136/bjophthalmol-2019-315217 · DOI
  167. Foreman, J., Keel, S., McGuiness, M., Liew, D., Wijngaarden, P., Taylor, H. R., & Dirani, M. (2020). Future burden of vision loss in Australia: projections from the national eye health survey. Clinical & Experimental Ophthalmology, 48(6), 730–738. https://doi.org/10.1111/ceo.13776 · doi:10.1111/ceo.13776
  168. Bikbov, M. M., Kazakbaeva, G. M., Gilmanshin, T. R., Zainullin, R. M., Nuriev, I. F., Zaynetdinov, A. F., Israfilova, G. Z., Panda-Jonas, S., Arslangareeva, I. I., Rakhimova, E. M., Rusakova, I. A., & Jonas, J. B. (2020). Prevalence and associated factors of cataract and cataract-related blindness in the Russian Ural Eye and Medical Study. Scientific Reports, 10(1), 18157. https://doi.org/10.1038/s41598-020-75313-0 · DOI
  169. Purola, P. K. M., Nättinen, J. E., Ojamo, M. U. I., Koskinen, S. V. P., Rissanen, H. A., Sainio, P. R. J., & Uusitalo, H. M. T. (2021). Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment. Quality of Life Research, 30(8), 2311–2327. https://doi.org/10.1007/s11136-021-02817-1 · DOI
  170. Tan, A. G., Tham, Y. C., Chee, M. L., Mitchell, P., Cumming, R. G., Sabanayagam, C., Wong, T. Y., Wang, J. J., & Cheng, C. Y. (2020). Incidence, progression and risk factors of age-related cataract in Malays: the Singapore Malay Eye Study. Clinical & Experimental Ophthalmology, 48(5), 580–592. https://doi.org/10.1111/ceo.13757 · DOI
  171. Vashist, P., Tandon, R., Murthy, G. V. S., Barua, C. K., Deka, D., Singh, S., Gupta, V., Gupta, N., Wadhwani, M., Singh, R., Vishwanath, K., Group, I.-E. S. S. (2020). Association of cataract and sun exposure in geographically diverse populations of India: The CASE study. First Report of the ICMR-EYE SEE Study Group. PLoS One, 15(1), e0227868. https://doi.org/10.1371/journal.pone.0227868 · DOI
  172. Lee, J., Kim, U. J., Lee, Y., Han, E., Ham, S., Lee, W., Choi, W. J., & Kang, S. K. (2021). Sunlight exposure and eye disorders in an economically active population: data from the KNHANES 2008–2012. Annals of Occupational and Environmental Medicine, 33, e24. https://doi.org/10.35371/aoem.2021.33.e24 · DOI
  173. Van Acker, S. I., van den Bogerd, B., Haagdorens, M., Siozopoulou, V., Ni Dhubhghaill, S., Pintelon, I., & Koppen, C. (2021). Pterygium—the good, the bad, and the ugly. Cells (Basel), 10(7), 1567. https://doi.org/10.3390/cells10071567 · DOI
  174. Rezvan, F., Khabazkhoob, M., Hooshmand, E., Yekta, A., Saatchi, M., & Hashemi, H. (2018). Prevalence and risk factors of pterygium: a systematic review and meta-analysis. Survey of Ophthalmology, 63(5), 719–735. https://doi.org/10.1016/j.survophthal.2018.03.001 · DOI · Paper page
  175. Liu, L., Wu, J., Geng, J., Yuan, Z., & Huang, D. (2013). Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open, 3(11), e003787. https://doi.org/10.1136/bmjopen-2013-003787 · DOI · Paper page
  176. Fernandes, A. G., Salomão, S. R., Ferraz, N. N., Mitsuhiro, M. H., Furtado, J. M., Muñoz, S., Cypel, M. C., Cunha, C. C., Vasconcelos, G. C., Sacai, P. Y., Morales, P. H., Cohen, M. J., Cohen, J. M., Watanabe, S. S., Campos, M., Belfort Junior, R., & Berezovsky, A. (2020). Pterygium in adults from the Brazilian Amazon Region: prevalence, visual status and refractive errors. British Journal of Ophthalmology, 104(6), 757–763. https://doi.org/10.1136/bjophthalmol-2019-314131 · doi:10.1136/bjophthalmol-2019-314131
  177. Pan, Z., Cui, J., Shan, G., Chou, Y., Pan, L., Sun, Z., Cui, Z., Sun, J., Cao, Y., Zhao, J., Ma, X., Ma, J., He, H., Ma, J., & Zhong, Y. (2019). Prevalence and risk factors for pterygium: a cross-sectional study in Han and Manchu ethnic populations in Hebei China. BMJ Open, 9(2), e025725. https://doi.org/10.1136/bmjopen-2018-025725 · DOI
  178. Wang, Y., Shan, G., Gan, L., Qian, Y., Chen, T., Wang, H., Pan, X., Wang, W., Pan, L., Zhang, X., Wang, M., Ma, J., & Zhong, Y. (2020). Prevalence and associated factors for pterygium in Han and Mongolian adults: a cross-sectional study in inner Mongolian, China. BMC Ophthalmology, 20(1), 45. https://doi.org/10.1186/s12886-020-1324-6 · DOI
  179. Hampel, U., Wasielica-Poslednik, J., Ries, L., Faysal, R., Schulz, A., Nickels, S., Wild, P. S., Schmidtmann, I., Münzel, T., Beutel, M. E., Lackner, K. J., Pfeiffer, N., & Schuster, A. K. (2021). Prevalence of pterygium and identification of associated factors in a German population—results from the Gutenberg Health Study. Acta Ophthalmologica, 99(1), e130–e131. https://doi.org/10.1111/aos.14505 · doi:10.1111/aos.14505
  180. Bikbov, M. M., Zainullin, R. M., Kazakbaeva, G. M., Gilmanshin, T. R., Salavatova, V. F., Arslangareeva, I. I., Nikitin, N. A., Panda-Jonas, S., Zaynetdinov, A. F., Kazakbaev, R. A., Nuriev, I. F., Khikmatullin, R. I., Uzianbaeva, Y. V., Yakupova, D. F., Aminev, S. K., & Jonas, J. B. (2019). Pterygium prevalence and Its associations in a Russian population: the ural eye and medical study. American Journal of Ophthalmology, 205, 27–34. https://doi.org/10.1016/j.ajo.2019.02.031 · doi:10.1016/j.ajo.2019.02.031
  181. Cameron, M. E. (1965). Pterygium Throughout the World. Springfield, IL: Charles C. Thomas
  182. Khanna, R. C., Marmamula, S., Cicinelli, M. V., Mettla, A. L., Giridhar, P., Banerjee, S., Shekhar, K., Chakrabarti, S., Murthy, G. V. S., Gilbert, C. E., & Rao, G. N. (2021). Fifteen-year incidence rate and risk factors of pterygium in the Southern Indian state of Andhra Pradesh. British Journal of Ophthalmology, 105(5), 619–624. https://doi.org/10.1136/bjophthalmol-2020-316359 · doi:10.1136/bjophthalmol-2020-316359
  183. Fang, X. L., Chong, C. C. Y., Thakur, S., Da Soh, Z., Teo, Z. L., Majithia, S., Lim, Z. W., Rim, T. H., Sabanayagam, C., Wong, T. Y., Cheng, C.-Y., & Tham, Y.-C. (2021). Ethnic differences in the incidence of pterygium in a multi-ethnic Asian population: the Singapore Epidemiology of Eye Diseases Study. Scientific Reports, 11(1), 501. https://doi.org/10.1038/s41598-020-79920-9 · DOI
  184. Lingham, G., Kugelman, J., Charng, J., Lee, S. S., Yazar, S., McKnight, C. M., Coroneo, M. T., Lucas, R. M., Brown, H., Stevenson, L. J., Mackey, D. A., & Alonso-Caneiro, D. (2021). Conjunctival ultraviolet autofluorescence area decreases with age and sunglasses use. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2021-320284. epub ahead of print. · doi:10.1136/bjophthalmol-2021-320284
  185. Goh, A. Y., Ramlogan-Steel, C. A., Jenkins, K. S., Steel, J. C., & Layton, C. J. (2020). Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma. Neoplasma, 67(5), 958–971. https://doi.org/10.4149/neo_2020_190815N768 · DOI
  186. Mundra, P. A., Dhomen, N., Rodrigues, M., Mikkelsen, L. H., Cassoux, N., Brooks, K., Valpione, S., Reis-Filho, J. S., Heegaard, S., Stern, M.-H., Roman-Roman, S., & Marais, R. (2021). Ultraviolet radiation drives mutations in a subset of mucosal melanomas. Nature Communications, 12(1), 259. https://doi.org/10.1038/s41467-020-20432-5 · DOI
  187. Ghazawi, F. M., Darwich, R., Le, M., Rahme, E., Zubarev, A., Moreau, L., Burnier, J. V., Sasseville, D., Burnier, M. N., & Litvinov, I. V. (2019). Uveal melanoma incidence trends in Canada: a national comprehensive population-based study. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2018-312966 · doi:10.1136/bjophthalmol-2018-312966
  188. Baily, C., O’Neill, V., Dunne, M., Cunningham, M., Gullo, G., Kennedy, S., Walsh, P. M., Deady, S., & Horgan, N. (2019). Uveal melanoma in Ireland. Ocular Oncology and Pathology, 5(3), 195–204. https://doi.org/10.1159/000492391 · doi:10.1159/000492391
  189. Aronow, M. E., Topham, A. K., & Singh, A. D. (2018). Uveal melanoma: 5-Year update on incidence, treatment, and survival (SEER 1973–2013). Ocular Oncology and Pathology, 4(3), 145–151. https://doi.org/10.1159/000480640 · doi:10.1159/000480640
  190. Beasley, A. B., Preen, D. B., McLenachan, S., Gray, E. S., & Chen, F. K. (2021). Incidence and mortality of uveal melanoma in Australia (1982–2014). British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2021-319700. epub ahead of print. · DOI
  191. Ghazawi, F. M., Darwich, R., Le, M., Jfri, A., Rahme, E., Burnier, J. V., Sasseville, D., Burnier, M. N., Jr., & Litvinov, I. V. (2020). Incidence trends of conjunctival malignant melanoma in Canada. British Journal of Ophthalmology, 104(1), 23–25. https://doi.org/10.1136/bjophthalmol-2019-313977 · DOI
  192. Virgili, G., Parravano, M., Gatta, G., Capocaccia, R., Mazzini, C., Mallone, S., Botta, L., Group R. A. W. (2020). Incidence and survival of patients with conjunctival melanoma in Europe. JAMA Ophthalmology, 138(6), 601–608. https://doi.org/10.1001/jamaophthalmol.2020.0531 · DOI
  193. Roberts, J. E. (2002). Screening for ocular phototoxicity. International Journal of Toxicology, 21(6), 491–500. https://doi.org/10.1080/10915810290169918 · DOI
  194. Zhao, B., Chignell, C. F., Rammal, M., Smith, F., Hamilton, M. G., Andley, U. P., & Roberts, J. E. (2010). Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics. Photochemistry and Photobiology, 86(4), 798–805. https://doi.org/10.1111/j.1751-1097.2010.00755.x · doi:10.1111/j.1751-1097.2010.00755.x
  195. Sahu, R. K., Singh, B., Saraf, S. A., Kaithwas, G., & Kishor, K. (2014). Photochemical toxicity of drugs intended for ocular use. Archives of Industrial Hygiene and Toxicology, 65(2), 157–167. https://doi.org/10.2478/10004-1254-65-2014-2461 · doi:10.2478/10004-1254-65-2014-2461
  196. Wright, C. Y., Lucas, R. M., D’Este, C., Kapwata, T., Kunene, Z., Swaminathan, A., Mathee, A., & Albers, P. N. (2019). Effect of a sun protection intervention on the immune response to measles booster vaccination in infants in rural South Africa. Photochemistry and Photobiology, 95(1), 446–452. https://doi.org/10.1111/php.13004 · DOI
  197. Swaminathan, A., Harrison, S. L., Ketheesan, N., van den Boogaard, C. H. A., Dear, K., Allen, M., Hart, P. H., Cook, M., & Lucas, R. M. (2019). Exposure to solar UVR suppresses cell-mediated immunization responses in humans: the Australian Ultraviolet Radiation and Immunity Study. Journal of Investigative Dermatology, 139(7), 1545-1553.e1546. https://doi.org/10.1016/j.jid.2018.12.025 · DOI
  198. LopatkoLindman, K., Lockman-Lundgren, J., Weidung, B., Olsson, J., Elgh, F., & Lövheim, H. (2022). Long-term time trends in reactivated herpes simplex infections and treatment in Sweden. BMC Infectious Diseases, 22(1), 547–547. https://doi.org/10.1186/s12879-022-07525-w · DOI
  199. Mai, Z.-M., Lin, J.-H., Ngan, R.K.-C., Kwong, D.L.-W., Ng, W.-T., Ng, A.W.-Y., Ip, K.-M., Chan, Y.-H., Lee, A.W.-M., Ho, S.-Y., Lung, M. L., & Lam, T.-H. (2020). Solar ultraviolet radiation and vitamin D deficiency on Epstein-Barr Virus reactivation: Observational and genetic evidence from a nasopharyngeal carcinoma-endemic population. Open Forum Infectious Diseases, 7(10), ofaa426. https://doi.org/10.1093/ofid/ofaa426 · DOI
  200. Bar-Or, A., Pender, M. P., Khanna, R., Steinman, L., Hartung, H. P., Maniar, T., Croze, E., Aftab, B. T., Giovannoni, G., & Joshi, M. A. (2020). Epstein-Barr virus in multiple sclerosis: theory and emerging immunotherapies. Trends in Molecular Medicine, 26(3), 296–310. https://doi.org/10.1016/j.molmed.2019.11.003 · DOI · Paper page

200 of 273 shown

Cited by

See all 162

Metadata

Authors
Neale, R. E., Lucas, R. M., Byrne, S. N., Hollestein, L., Rhodes, L. E., Yazar, S., Young, A. R., Berwick, M., Ireland, R. A., & Olsen, C. M.
Venue
Photochemical & Photobiological Sciences
Published
2023-03-01
Volume
22
Issue
5
Pages
1011-1047
ISSN
  • 1474-905X (ISSN-L)
  • 1474-9092
OpenAlex
W4322719113
Cited by
162
References
20
FWCI
36.81
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
The University of Queensland

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of exposure to solar radiation on human health. https://app.cochat.ai/papers/10.1007/s43630-023-00375-8
The paper
Neale, R. E., Lucas, R. M., Byrne, S. N., Hollestein, L., Rhodes, L. E., Yazar, S., Young, A. R., Berwick, M., Ireland, R. A., & Olsen, C. M. (2023). The effects of exposure to solar radiation on human health. Photochemical & Photobiological Sciences. https://doi.org/10.1007/s43630-023-00375-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.